Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 80/100

Termination Rate

33.3%

2 terminated out of 6 trials

Success Rate

0.0%

-86.5% vs benchmark

Late-Stage Pipeline

33%

2 trials in Phase 3/4

Results Transparency

0%

1 of 0 completed with results

Key Signals

1 with results0

Data Visualizations

Phase Distribution

6Total
Not Applicable (4)
P 3 (1)
P 4 (1)

Trial Status

Not Yet Recruiting2
Terminated2
Recruiting1
Unknown1

Clinical Trials (6)

Research Network

Activity Timeline